UGA, GRA recruit Parkinson’s researcher Anu Kanthasamy as Eminent Scholar
Emory’s COVID-19 drug, now molnupiravir, shows great promise · UGA is no. 1 for getting new products to market · GRA-backed Hypercell protects...
In this issue:
- Emory’s COVID-19 drug, now molnupiravir, shows great promise
- UGA is no. 1 for getting new products to market
- GRA-backed Hypercell protects livestock — and people
- Morehouse School of Medicine gets $1.1M grant to expand telehealth
- Georgia Tech center enters European partnership
- 3 startups with GRA investment make TAG ‘Top 40’ list
- GRA Eminent Scholar John Crittenden receives high honors
- GRA represented in Georgia Bio’s Helix awards